What is CVE-2022-48224?

CVE-2022-48224 is a high-severity vulnerability in Gbgplc Acuant Acufill Sdk, classified under Uncontrolled Search Path Element. CVSS score: 7.3/10. Published 2023-04-04.

How severe is CVE-2022-48224?

High severity. CVSS v3 base score is 7.3 out of 10.

Vulnerability in Gbgplc Acuant Acufill Sdk

CVE-2022-48224

An issue was discovered in Acuant AcuFill SDK before 10.22.02.03. It is installed with insecure permissions (full write access within Program Files). Standard users can replace files within this directory that get executed with elevated privileges, leading to a complete arbitrary code execution (elevation of privileges).

EPSS: 0.002 (12.2th percentile) — read the EPSS interpretation.

CVSS v3 metric

CVSS v3 base score 7.3 (High). Vector: CVSS:3.1/AV:L/AC:L/PR:L/UI:R/S:U/C:H/I:H/A:H.

Affected products

Gbgplc Acuant_acufill_sdk
N/a — versions n/a

Weakness classification (CWE)

CWE-427 — Uncontrolled Search Path Element

References

cve@mitre.org (Not Applicable)
cve@mitre.org (Third Party Advisory)

Frequently asked questions

What is CVE-2022-48224?: CVE-2022-48224 is a high-severity vulnerability in Gbgplc Acuant Acufill Sdk, classified under Uncontrolled Search Path Element. CVSS score: 7.3/10. Published 2023-04-04.
How severe is CVE-2022-48224?: High severity. CVSS v3 base score is 7.3 out of 10.